LINNO

Linno is dedicated to develop cutting-edge enabling technologies and novel therapeutic products to address major challenges in management of chronic human diseases. With proprietary Nano Brain-pass technology which enables blood-brain barrier-penetrating drug delivery for multiple forms of moieties, and next-generation pathway-selective complement inhibitors, Linno is working with partners to develop first- or best-of-class therapeutics, including orphan drugs for rare and devastating diseases... Leveraging the proprietary technologies, Linno is working with partners to develop the first- or best-in-class therapeutics, including orphan drugs for rare and devastating diseases that have no available treatment exist yet.

Primary location: Shanghai China